Real-Time Clinical Trials (RTCTs): FDA’s Next Regulatory Revolution and What Sponsors Must Do Now
Date: August 20, 2026
Duration: 60 Minutes
Time: 12 PM EST
The U.S. FDA has launched a groundbreaking initiative to implement Real-Time Clinical Trials (RTCTs)—a transformative approach that could fundamentally reshape how clinical trials are conducted, monitored, and reviewed. By enabling continuous access to clinical trial data rather than relying solely on end-of-study submissions, the FDA aims to accelerate regulatory decision-making, strengthen patient safety oversight, and modernize the clinical development process.
For sponsors, CROs, clinical researchers, and regulatory professionals, this is more than a technological advancement—it signals a significant shift in regulatory expectations and clinical trial operations. Organizations that understand and prepare for this evolving model today will be better positioned to adapt to future FDA requirements, while those that delay may face new operational and compliance challenges.
This premium webinar has been developed for professionals who want to move beyond the FDA’s announcement and gain a strategic understanding of what Real-Time Clinical Trials will mean in practice. Rather than simply reviewing the news, the session will examine the regulatory rationale behind RTCTs, the technologies that make them possible, their impact on regulatory submissions, data governance, quality systems, inspection readiness, and organizational preparedness.
Participants will gain practical insights into how continuous data collection, digital health technologies, artificial intelligence, cloud-based clinical platforms, decentralized trial models, and advanced analytics are expected to work together to support FDA’s vision for faster and smarter clinical development.
What You Will Learn
During this comprehensive webinar, our expert speaker will discuss:
- The FDA’s vision and long-term strategy for implementing Real-Time Clinical Trials.
- Why traditional clinical trial models are evolving and the regulatory challenges driving this transformation.
- The core principles and operating framework of Real-Time Clinical Trials.
- How continuous data collection differs from conventional clinical trial processes.
- The role of Digital Health Technologies (DHTs), wearable devices, eSource, ePRO, remote monitoring, artificial intelligence, and cloud-based clinical systems in enabling real-time trials.
- Regulatory implications for IND, NDA, BLA, IDE, PMA, and other FDA submissions.
- How RTCTs may influence data standards, clinical data management, monitoring strategies, and regulatory interactions.
- Emerging challenges related to data integrity, cybersecurity, AI governance, vendor oversight, and inspection readiness.
- The potential impact of continuous FDA visibility into ongoing clinical studies.
- A practical framework for assessing your organization’s readiness for the future of real-time clinical research.
Why You Should Attend
The FDA’s Real-Time Clinical Trial initiative has the potential to become one of the most significant regulatory developments in clinical research over the coming decade. Understanding its implications early will help organizations prepare for evolving regulatory expectations while strengthening their clinical development capabilities.
This webinar is designed to provide practical, actionable knowledge that extends far beyond publicly available information. You will gain a strategic perspective on where FDA is heading, how these changes may affect your organization, and the steps you can begin taking today to prepare for future regulatory and operational requirements.
By attending, you will be able to:
- Understand the regulatory science behind FDA’s Real-Time Clinical Trial initiative.
- Identify the technologies and infrastructure needed to support continuous clinical data review.
- Evaluate the impact of RTCTs on regulatory submissions, quality systems, and inspection readiness.
- Recognize new compliance risks associated with continuous data sharing and AI-enabled oversight.
- Learn practical strategies to improve organizational preparedness for future FDA expectations.
- Stay ahead of industry trends and position your organization for the next generation of clinical development.
Who Should Attend
This webinar is ideal for professionals involved in clinical research, regulatory strategy, quality, and product development, including:
- Regulatory Affairs Professionals
- Clinical Operations Managers and Directors
- Clinical Trial Managers
- Clinical Project Managers
- Clinical Data Managers
- Biostatisticians
- Medical Affairs Professionals
- Pharmacovigilance and Drug Safety Professionals
- Quality Assurance and GCP Compliance Professionals
- Clinical Research Associates (CRAs)
- Clinical Research Organizations (CROs)
- Pharmaceutical, Biotechnology, and Medical Device Companies
- Digital Health and Clinical Technology Teams
- Executive Leadership responsible for Clinical Development and Regulatory Strategy
Speaker: Mukesh Kumar
PhD, RAC | CEO, FDAMap
For more info, fill the box below. We will contact you within 24 hrs.
Bonus Resources Included
Every registered participant will receive exclusive reference materials designed to support implementation and organizational planning, including:- Real-Time Clinical Trial Readiness Assessment Checklist
- FDA RTCT Regulatory Impact Checklist
- RTCT Technology and Digital Health Reference Guide
- Executive Briefing Paper: Preparing Your Organization for FDA’s Real-Time Clinical Trial Future
These valuable resources will help attendees evaluate their current capabilities and begin developing a roadmap for future readiness.
Why Choose This Webinar?
Unlike introductory webinars that simply summarize FDA announcements, this session provides an expert-level analysis of the regulatory, operational, technological, and compliance implications of Real-Time Clinical Trials. The content has been specifically developed for professionals seeking strategic guidance, practical implementation insights, and a deeper understanding of how FDA’s modernization efforts may shape the future of clinical research.
Whether you are responsible for regulatory submissions, clinical operations, quality systems, digital transformation, or executive decision-making, this webinar will provide the knowledge and practical framework needed to prepare your organization for one of the most significant changes in modern clinical development.
Webinar Fee
Prices are in US Dollars.
The registration fee includes: The live webinar & all related course materials.
Terms & Conditions to register for the Webinar
Your Registration for the workshop is subject to following terms and conditions. If you need any clarification before registering for this webinar please email us at info@fdamap.com
Payment
We accept credit card, debit card, and PayPal.
Cancellations & Substitutions:
Written cancellations through fax or email (from the person who has registered for this conference) received at least 5 business days prior to the start date of the event will receive a refund — less a $30 administration fee. No cancellations will be accepted — nor refunds issued — within 5 business days before the start date of the event. You may however, choose to substitute the webinar for which you are registered with some other webinar in the future.
On request by email or fax (before the seminar) a credit for the amount paid minus administration fees ($30) will be transferred to any future FDA Map event and a credit note will be issued. No-shows will be charged the full amount.
Webinar material will be uploaded on the website 24 hours before the scheduled date of the webinar. In case it is not available on the website due to some technical issues, we will email the material a few hours before the start of the webinar.
In the event FDA Map cancels the webinar, FDA Map will issue a full refund to all the registrants for that webinar. Some topics and speakers may be subject to change without notice.
